AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
Log in

NASDAQ:FGENFibroGen SEC Filings & 10K Form

$41.82
-0.09 (-0.21 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$41.18
Now: $41.82▼
$42.11
50-Day Range
$32.64
MA: $38.15▼
$43.50
52-Week Range
$22.65
Now: $41.82▼
$48.95
Volume304,300 shs
Average Volume707,554 shs
Market Capitalization$3.73 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.58

SEC Filings

FibroGen (NASDAQ:FGEN) SEC Filings

DateFilerForm TypeView
06/24/2020
7:51 PM		FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
7:47 PM		FibroGen (Issuer)
Wettig Thane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2020
3:59 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
5:35 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
5:59 AM		Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
8:22 PM		FibroGen (Issuer)
Rosenkranz Roberto Pedro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:48 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:47 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:46 PM		FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:45 PM		FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:34 PM		FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:33 PM		FibroGen (Issuer)
Rosenkranz Roberto Pedro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:32 PM		FibroGen (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:31 PM		FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:30 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:28 PM		FibroGen (Issuer)
KEARNS THOMAS F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:27 PM		FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:26 PM		FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:25 PM		EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:23 PM		Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
3:05 PM		FibroGen (Filer)
Form DEF 14A
03/24/2020
4:24 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
4:37 PM		FibroGen (Issuer)
KEARNS THOMAS F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:55 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
7:05 PM		FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
7:03 PM		FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
7:00 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:06 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:27 PM		FibroGen (Subject)
Neff Thomas B (Filed by)
Form SC 13G/A
02/13/2020
4:36 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
8:52 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2020
3:40 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
8:01 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
8:16 PM		FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:14 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:12 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:10 PM		Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:09 PM		Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2020
4:23 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2019
3:25 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
8:06 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
7:33 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:38 PM		FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:08 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
7:13 PM		FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
7:11 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
7:10 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
6:51 PM		FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
6:10 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
5:07 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
8:15 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:23 AM		FibroGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:16 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
5:05 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
1:05 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
1:00 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
10:49 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
6:57 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
7:26 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
4:14 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
8:01 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
5:57 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
5:00 PM		FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
8:00 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
6:45 PM		FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
6:42 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:33 PM		FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:31 PM		FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:29 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:28 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:26 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
10:21 AM		FibroGen (Filer)
Form CT ORDER
09/04/2019
10:15 AM		FibroGen (Filer)
Form CT ORDER
09/04/2019
10:10 AM		FibroGen (Filer)
Form CT ORDER
09/04/2019
10:05 AM		FibroGen (Filer)
Form CT ORDER
09/04/2019
9:59 AM		FibroGen (Filer)
Form CT ORDER
09/04/2019
9:54 AM		FibroGen (Filer)
Form CT ORDER
09/04/2019
9:24 AM		FibroGen (Filer)
Form CT ORDER
08/26/2019
6:33 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
8:04 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:49 PM		FibroGen (Issuer)
Neff Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:39 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
4:38 PM		FibroGen (Issuer)
Neff Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
4:12 PM		FibroGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
3:15 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:42 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:31 PM		FibroGen (Issuer)
Neff Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
8:46 PM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
7:00 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
3:27 PM		FibroGen (Issuer)
Neff Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:23 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
7:18 PM		FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
7:11 PM		FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
8:01 AM		FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
3:47 PM		FibroGen (Issuer)
Neff Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
5:19 PM		FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
5:18 PM		Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
5:15 PM		Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:55 PM		FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
7:24 PM		Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.